Tag Archives: Lawsuit

Surgical Mesh Lawsuit News: Bernstein Liebhard LLP Notes Current Creation of New Federal Vaginal Mesh Litigation in Southern District of West Virginia

Posted on by


New York, NY (PRWEB) June 26, 2013

Surgical mesh lawsuit claims are continuing to move forward in a number of federal litigations at present underway in the Southern District of West Virginia, Bernstein Liebhard LLP reports.

&#13

According to court documents, a federal multi-district litigation for claims involving transvaginal mesh manufactured by Cook Healthcare, Inc. was authorized on June 11th by the U.S. Judicial Panel on Multidistrict Litigation. The initial status conference for this proceeding has been scheduled for August 1st at 9:00 a.m.* (In Re: Cook Medical, Inc., Pelvic Repair Technique Goods Liability Litigation – MDL No. 2440)

&#13

Lawsuits alleging injuries brought on by the companys mesh are now pending in the federal proceeding underway in the U.S. District Court, Southern District of West Virginia, where claims involving merchandise from American Medical Systems, C.R. Bard, Boston Scientific and Johnson &amp Johnsons Ethicon unit have currently been filed in separate litigations. On the date the Cook Health-related litigation was approved, court records indicate there had been 13 instances filed against the manufacturer in eight federal jurisdictions in the U.S.

&#13

Given how numerous women we hear from who have sustained mesh erosion, vaginal scarring and other injuries allegedly due to transvaginal mesh merchandise, we are not surprised that far more of these varieties of products are becoming the object of litigation, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is actively filing transvaginal mesh lawsuits on behalf of women who allegedly suffered pain, vaginal scarring, mesh erosion, infection and other injuries.

&#13

Surgical Mesh Lawsuits

&#13

In addition to lawsuits now pending in the recently developed federal litigation involving Cook Health-related mesh devices, thousands of claims have been filed in the four other transvaginal mesh proceedings established in the U.S. District Court, Southern District of West Virginia. These lawsuits have been filed by women who allegedly seasoned complications stemming from mesh erosion by means of the vaginal tissue, which could manifest in infection, discomfort, vaginal scarring, and other injuries. As a result, plaintiffs in these circumstances allege they now endure a diminished quality of life.

&#13

Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs Steering Committees in the following four federal vaginal mesh litigations: In re: American Health-related Systems, Inc., Pelvic Repair Systems Merchandise Liability Litigation (MDL No. 2325) In re: Boston Scientific Corp., Pelvic Repair Systems Items Liability Litigation (MDL No. 2326) In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2187) and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation ( MDL No. 2327).

&#13

The scrutiny surrounding this class of devices has continued to mount given that 2008, when the U.S. Meals and Drug Administration (FDA) issued its initial public overall health alert warning the public that it had received far more than 1,000 adverse event reports from women implanted with the surgical material.** In 2011, the agency revised its stance on the frequency of these complications to occur from rare to not uncommon following finding that the number of complaints from vaginal mesh individuals improved 5-fold over a period of 3 years.***

&#13

Girls who could have been injured by transvaginal mesh may be eligible to get compensation for out-of-pocket medical costs, as well as lost wages, pain and suffering and other damages. Find out far more about surgical mesh lawsuits by going to Bernstein Liebhard LLP’s site. To speak with a mesh lawyer straight, call 800-511-5092.

&#13

*wvsd.uscourts.gov/MDL/2440/pdfs/PTO_1.pdf&#13

**fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm079028.htm&#13

***fda.gov/MedicalDevices/Security/AlertsandNotices/PublicHealthNotifications/ucm061976.htm

&#13

About Bernstein Liebhard LLP

&#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated individual and class action lawsuits nationwide because 1993, including these who have been harmed by harmful drugs, defective healthcare devices and consumer items. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the prime plaintiffs firms in the country, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Fresenius NaturaLyte, GranuFlo Dialysis Heart Attack Lawsuit Allegations Update: FDA Cites Dialysis Center over Deficiencies as Much more Situations Filed

Posted on by

San Diego, CA (PRWEB) June 27, 2013

http://www.resource4thepeople.com/defectivemedicaldevices/Dialysis-Lawsuit.html

&#13

Resource4thePeople reports nowadays on its most current update to shoppers who are following the litigation involving allegations that Fresenius NaturaLyte and GranuFlo kidney dialysis products brought on life-threatening troubles for individuals.

&#13

The most current news is that as a federal judge moves forward on consolidated federal lawsuits* involving these allegations a search of U.S. Food and Drug Administration records shows that Fresenius was cited** by federal regulators more than deficiencies uncovered at 1 of the companys facilities.

&#13

In a warning letter dated March 13, 2013, FDA officials informed Fresenius Health-related Care officials that dialyzers manufactured at the companys Ogden, Utah plant are not in conformity with existing federal good manufacturing requirements.

&#13

The FDAs warning letter additional calls into query the good quality of goods that Fresenius is producing for kidney individuals and comes at a time when the federal court method has consolidated situations from across the nation containing allegations that GranuFlo and NaturaLyte allegedly have life-threatening side effects, stated Resource4thePeople.

&#13

We will continue to supply updates for shoppers who may possibly have been impacted by these dialysis goods and will report on the progress of the federal consolidated litigation. We also will continue to offer buyers free consultations about legal rights to which they may be entitled to seek compensation.

&#13

At least 161 federal NaturaLyte and GranuFlo lawsuits alleging severe heart difficulties and deaths from the use of these merchandise have been consolidated ahead of U.S. District Court Judge Douglas P. Woodlock, according to the court docket.*

&#13

The court filings also summarize the particular allegations involved that plaintiffs who used NaturaLyte and GranuFlo claim they must be compensated for:

&#13

These actions share factual troubles arising from allegations that Plaintiffs suffered injury or death brought on by the use of GranuFlo and/or NaturaLyte products in the course of hemodialysis, which allegedly might cause metabolic alkalosis in sufferers resulting in low blood stress, hypokalemia, hypoxemia, hypercapnia, cardiac arrhythmia, or cardiopulmonary arrest.

&#13

All the actions involve factual concerns relating to whether or not GranuFlo and NaturaLyte were defectively developed or manufactured, no matter whether Fresenius, the manufacturer of these dialysate goods, knew or ought to have known of the alleged propensity of these merchandise to result in injury and whether or not it supplied adequate directions and warnings with these goods.

&#13

Resource4thePeople, in response to inquiries from consumers, is informing them that even although this multidistrict litigation has been produced new inquiries will nevertheless be accepted and further circumstances will continue to be filed.

&#13

Amongst numerous new situations that have been not too long ago filed are those by:&#13

&#13

Da Vinci Lawsuit News: Bernstein Liebhard LLP Notes Recent FDA Letter Stating Intuitive Surgical Could Have Violated Federal Regulations Regarding its da Vinci Robot

Posted on by


New York, NY (PRWEB) June 27, 2013

In a current notice from the U.S. Meals and Drug Administration (FDA) that might impact da Vinci lawsuit claims, the agency states that Intuitive Surgical possibly violated federal law by failing to initial alert regulators when it warned consumers about difficulties with the da Vinci Surgical Program, Bernstein Liebhard LLP reports.

&#13

According to the letter issued May 30th by the FDA, Intuitive Surgical received 134 complaints and filed 83 medical device reports stemming from use of the device between January 2010 and December 2011.* Following these reports, Intuitive sent a letter to buyers in October 2011 providing ideas and recommendations for appropriate use of the da Vinci Surgical Technique. According to a CNBC.com report published on June 25th, the FDA said Intuitive Surgical wrote to its customers in response to complaints concerning arcing by way of broken tip covers that caused patient injury.**

&#13

Intuitive Surgicals failure to very first notify the FDA begs the question of whether or not they were attempting to hide one thing from the regulator. We will be watching this improvement carefully. Our Firm continues to hear from individuals who allegedly skilled surgical burns, excessive bleeding and other critical undesirable robot surgery complications stemming from use of the da Vinci Surgical Technique, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and healthcare devices. The Firm is presently supplying totally free and confidential case evaluations to individuals who may have experienced robotic surgery complications after undergoing a procedure aided by the da Vinci Surgical System. Da Vinci Lawsuit Claims

&#13

According to a statement issued April 19th by Intuitive Surgical, 26 da Vinci lawsuits alleging complications due to the surgery robot had been filed in the U.S. Court records indicate that the nations very first trial for a claim alleging robotic surgery complications concluded with a ruling in favor of Intuitive last month, but a May possibly 23rd report from Bloomberg.com stated that the lawyer for the plaintiff in the case was optimistic that future lawsuits more than the da Vinci Surgery Robot would result in favorable outcomes for allegedly injured sufferers.***(Estate of Fred E. Taylor v. Intuitive Surgical, 09-two-03136-5, Superior Court, State of Washington, Kitsap County)

&#13

In a regulatory filing with the U.S. Securities and Exchange Commission issued by Intuitive on April 19th, the manufacturer reported that it had entered tolling agreements in specific bad robot surgery lawsuits more than its da Vinci Surgical System to allow additional time to evaluate the claims, to discover regardless of whether the claims have merit and whether they can be resolved without having litigation.**** As of March 14th, 2013, a notice entered in the U.S. District Court, Eastern District of Louisiana on March 14th indicated that Intuitive had settled a lawsuit alleging injuries sustained by a woman whose thyroid process was aided by the da Vinci robot. (Silvestrini v. Intuitive Surgical Systems Inc., No. 11-2704 (E.D. La.))

&#13

The da Vinci Surgical Method was authorized in 2000 to aid surgeons performing minimally-invasive laparoscopic, urologic and gynecologic procedures. The device is now also utilized in thousands of hysterectomies, gall bladder and prostate removal surgeries, thyroid cancer procedures and heart surgeries, according to a Bloomberg.com report from February 28th.*****

&#13

Individuals who knowledgeable robotic surgery complications may possibly be entitled to compensation for healthcare bills, lost wages, discomfort and suffering and other damages incurred by their injuries. Understand a lot more about bad robot surgery complications by visiting Bernstein Liebhard LLPs website. To speak with one of the Firms attorneys, please call 800-511-5092.

&#13

*fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM358468.pdf&#13

**cnbc.com/id/100843549&#13

***bloomberg.com/news/2013-05-23/intuitive-wins-trial-defeats-negligent-coaching-claims.html&#13

****sec.gov/Archives/edgar/data/1035267/000119312513162385/d508282d10q.htm &#13

*****bloomberg.com/news/2013-05-23/intuitive-wins-trial-defeats-negligent-education-claims.html

&#13

About Bernstein Liebhard LLP

&#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide since 1993, which includes those who have been harmed by dangerous drugs, defective health-related devices and consumer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the leading plaintiffs firms in the nation, for the past 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Advertising.

Baron and Budd Law Firm Tackles Fresenius GranuFlo Lawsuit

Posted on by


Dallas, TX (PRWEB) June 28, 2013

A MDL Statistics Report issued on May possibly 14th by the U.S. Judicial Panel on Multidistrict Litigation (JPML) claims that at least 161 Fresenius GranuFlo lawsuit situations have been filed in federal litigation in the district of Massachusetts considering that March. (IN RE: FRESENIUS GRANUFLO/NATURALYTE DIALYSATE LITIGATION, MDL NO. 2428)

&#13

People who have allegedly suffered severe injuries including cardiac arrest and heart attacks from these merchandise continue to speak to us, said Russell Budd, founder and managing shareholder of Baron and Budd, a national plaintiffs law firm handling GranuFlo lawsuit cases. At this time we have begun offering free GranuFlo lawsuit evaluations to these dialysis sufferers and their loved ones. As GranuFlo was a extensively employed dialysis product, we expect the quantity of GranuFlo lawsuit instances to continue to improve.

&#13

Both GranuFlo and NaturaLyte have been discussed in an Urgent Solution Notification sent by the dialysis drugs manufacturer Fresenius Healthcare Care to its client clinics in March of 2012 that pointed out achievable heart dangers linked with GranuFlo and NaturaLyte use. The U.S. Food and Drug Administration (FDA) took notice of the notification a number of months later and issued a Class 1 GranuFlo recall, a classification that is only issued when a healthcare item has a significant threat of serious injury or death. (http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm FDA, March 29, 2013)

&#13

According to court documents, GranuFlo lawsuit litigation was established by an order of the JPMB on March 29th. At the time, 11 Fresenius GranuFlo lawsuit instances had been transferred to the proceeding. In these GranuFlo lawsuit cases, plaintiffs allege that Fresenius Health-related Care was conscious of the significant heart risks linked with their goods, GranuFlo and NaturaLyte, and failed to sufficiently warn sufferers and doctors relating to the complete scope of the dangers.

&#13

In compliance with GranuFlo lawsuit litigation, dialysis sufferers who allegedly suffered critical heart injuries from GranuFlo and NaturaLyte use, like sudden heart attacks and sudden cardiac death, within 48 hours of dialysis therapy might have the opportunity to file a GranuFlo lawsuit against manufacturer Fresenius to receive compensation for lost wages, pain and suffering and healthcare costs. To find out much more about the GranuFlo lawsuit pay a visit to Baron and Budds site http://baronandbudd.com/regions-of-practice/pharmaceuticals/granuflo-lawyer/ or call Baron and Budds Chief GranuFlo lawyer at 1.866.844.4556.

&#13

If you or an individual you know has undergone dialysis treatments employing the GranuFlo or NaturaLyte dialysis drug and suffered severe overall health injuries, speak to Baron and Budds chief GranuFlo lawyer nowadays at 1.866.855.4556 or e-mail our chief GranuFlo lawyer at information (at) baronbudd (dot) com.

&#13

Baron and Budd has a effectively-established record of good results safeguarding the rights of individuals against large, negligent corporations, such as pharmaceutical organizations, for over 35 years. Recently, Baron and Budd lawyers were involved in litigation surrounding the diabetes drug Avandia. Baron and Budd represented more than 7,000 patients allegedly harmed by Avandia use, and presently represents numerous states in lawsuits against the manufacturer GlaxoSmithKline (In Re: Avandia Marketing and advertising, Sales Practices and Products Liability Litigation, MDL No. 1871, E.D. Pa.). In the 1990s, Baron and Budd was closely involved in litigation surrounding the then-common diet plan drug Fen-Phen. The resulting settlement was valued at over $ 1.275 billion (In re Diet regime Drugs (Phentermine | Fenfluramine | Dexfenfluramine) Goods Liability Litigation, Case No. 98- MDL No. 1203 (E.D. Pa.).

&#13

About Baron &amp Budd

&#13

With offices in Dallas, Baton Rouge, Austin and Los Angeles, the law firm Baron Budd is nationally recognized with over 35 years of Protecting Whats Right for individuals, communities and firms harmed by negligence. Baron &amp Budds size and sources allow the firm to take on massive and complex circumstances. The firm represents individuals, governmental and enterprise entities in locations as diverse as water contamination, Gulf oil spill, Qui Tam, California Proposition 65 violations, unsafe drugs and health-related devices, Chinese drywall, deceptive marketing, consumer economic fraud, securities fraud and asbestos cancers such as mesothelioma.

&#13
&#13
&#13
&#13
&#13

A lot more Administrator Press Releases

Byetta Lawsuit Website Launched by Bernstein Liebhard LLP Gives Updated Byetta Pancreatic Cancer Details, Developing Investigation and Litigation

Posted on by


New York, NY (PRWEB) June 28, 2013

Bernstein Liebhard LLP has launched a new Byetta lawsuit website devoted to supplying data to patients who could have created pancreatitis, pancreatic cancer or thyroid cancer as a result of the diabetes drug.

&#13

The Firm is actively investigating the hazardous pancreatic dangers related with Byetta, a sort II diabetes drug involved in a class of drugs known as incretin mimetics. In addition to its new internet site, which contains information associated to side effects, as effectively as updates on the increasing nationwide litigation involving Byetta and other incretin mimetics which includes Januvia, Bernstein Liebhard LLP is providing totally free and confidential case evaluations to any person who may possibly have been diagnosed with any of the following diseases soon after taking the diabetes medication:&#13

&#13

GranuFlo Lawsuit Update: New Filings Highlight Alleged Hyperlink of GranuFlo to Cardiac Arrest, Reports Audet and Partners, LLP

Posted on by


San Francisco, CA (PRWEB) July 01, 2013

A new federal lawsuit filed in the United States District Court for the Southern District of Iowa (Case No. three:2013cv00073) alleges that the dialysis drug GranuFlo triggered the plaintiff to endure a heart attack shortly following dialysis therapy, causing a fatal collision.* This case has been added to federal multidistrict litigation No.2428 now pending before Judge Douglas P. Woodlock in Massachusetts, which lists 161 pending instances as component of this litigation.**

&#13

Numerous internal memoranda circulated inside Fresenius, the maker of GranuFlo, suggest that Fresenius might have identified of the heart attack threat associated with its merchandise use, even prior to an FDA recall.*** This enhanced danger is linked to elevated bicarbonate levels, a contributing factor in cardiac arrest.***

&#13

Since of the hazardous nature of GranuFlo, the FDA has issued a Class I recall of GranuFlo.**** In issuing the recall, the FDA warned buyers that the elevated sodium bicarbonate levels, could contribute to metabolic alkalosis, which is a substantial threat issue associated with low blood stress, hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not appropriately treated, may culminate in cardiopulmonary arrest.**** The FDA concluded by stating that the serious adverse wellness consequences related with GranuFlo could even consist of death.****

&#13

Attorney William Audet, whose law firm Audet and Partners, LLP represents several plaintiffs in active lawsuits against Fresenius, is not surprised by the new lawsuit filings. “The complaints being added to the multidistrict litigation echo troubles articulated by men and women with whom we continue to speak on a weekly basis. These problems frequently involve heart attacks or cardiac arrest occurring inside hours following dialysis treatment options involving the administration of GranuFlo. The evidence emerging by way of discovery suggests that Fresenius may possibly have failed to act in a responsible style upon becoming conscious of this potential heart attack hyperlink a number of years ago.”

&#13

If you or somebody you know has suffered an injury that might be connected to GranuFlo, please get in touch with Audet &amp Partners, LLP by calling us toll cost-free at 800.965.1461. For extra data, you can visit our informational internet site at http://www.granuflodialysisrisk.com. &#13

&#13
U.S. District Court for the Southern District of Iowa, Case No. 3:2013cv00073

** United States Judicial Panel on Multidistrict Litigation, May 14, 2013 http://www.jpml.uscourts.gov/websites/jpml/files/Pending%20MDL%20Dockets_By%20District_Could-14-2013.pdf

&#13

*** New York Times, June 15, 2012 http://www.nytimes.com/2012/06/15/wellness/fda-investigates-fresenius-for-failure-to-warn-of-risk.html

&#13

**** FDA, May 25, 2012 http://www.fda.gov/Security/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305630.htm

&#13
&#13
&#13
&#13
&#13

Far more Administrator Press Releases

Transvaginal Mesh Lawsuit News: Federal Judge Overseeing American Healthcare Systems Surgical Mesh Lawsuits Selects Bellwether Instances, Bernstein Liebhard LLP Reports

Posted on by


New York, New York (PRWEB) July 02, 2013

Transvaginal mesh lawsuit claims involving items manufactured by American Medical Systems, Inc. continue to move forward in a federal multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to a Pretrial Order issued by the Court on July 1, 2013, four surgical mesh lawsuits have been chosen for the litigations bellwether trials. The proceedings initial trial is scheduled to start on December 3, 2013, even though a second is slated to start off on Might six, 2014. U.S. District Judge Joseph R. Goodwin will soon establish which of the 4 bellwether instances will go to trial on those dates, according to the Order. (In Re: American Health-related Systems, Inc., Pelvic Repair Systems Items Liability Litigation – MDL No. 2325)

&#13

We are incredibly pleased to see these claims moving forward. The bellwether trials will give important clues into how other juries may possibly weigh claims in similar surgical mesh lawsuits involving American Medical Systems, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and health-related devices. The Firms vaginal mesh lawyers are currently representing hundreds of girls who allegedly suffered mesh erosion, discomfort, scarring, infection and other serious injuries, allegedly due to transvaginal mesh merchandise marketed by American Health-related Systems and other manufacturers. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs Steering Committee in the American Healthcare Systems litigation.

&#13

American Health-related Systems Transvaginal Mesh Lawsuits

&#13

Court documents indicate that a lot more than 7,700 surgical mesh lawsuits have been filed against American Healthcare Systems in the Southern District of West Virginia. All of the lawsuits pending in the litigation allege that American Healthcare Systems failed to provide adequate warnings with regards to the dangers linked with surgical mesh utilized to treat pelvic organ prolapse and stress urinary incontinence. It is additional alleged that plaintiffs suffered a range of serious complications due to the defective nature of these items, including chronic infections, organ harm, and mesh erosion and shrinkage.

&#13

The litigation surrounding transvaginal mesh devices utilized to treat pelvic organ prolapse and stress urinary incontinence has been expanding given that October 2008, when the U.S. Food &amp Drug Administration (FDA) warned the public that it had received a lot more than 1,000 reports of serious complications linked with vaginal mesh products over a 3 year period.* Less than 3 years later, in July 2011, the FDA warned that complaints related with transvaginal prolapse repair had grown 5-fold because the 2008 alert, and stated that it no longer regarded as these varieties of injuries to be uncommon.**

&#13

American Healthcare Systems is just 1 of many producers involved in litigations for surgical mesh lawsuits established in the Southern District of West Virginia. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs Steering Committees for proceedings involving Boston Scientific Corp., (MDL No. 2326) C.R. Bard, Inc., (MDL No. 2187), and In re: Ethicon, Inc. (MDL No. 2327). Court documents show that the very first of the litigations bellwether trials, involving a C.R. Bard product, is scheduled to start on July 8, 2013.

&#13

Mr. Grand has also been named Co-Liaison Counsel in two consolidated litigations established for C.R. Bard and Ethicon transvaginal mesh lawsuits that are at present underway in New Jerseys Atlantic County Superior Court. He was also a member of the trial group on the very first Ethicon trial in that proceeding, which ended in March with an $ 11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-ten In re: Pelvic Mesh Litigation/Bard, No. L-6339-ten)

&#13

Ladies who have allegedly suffered severe complications related with transvaginal mesh may possibly be entitled to compensation for their healthcare bills, discomfort and suffering, and other injuries. A wealth of data with regards to transvaginal mesh lawsuits is obtainable at Bernstein Liebhard’s web site. To arrange for a free of charge legal consultation with an experienced mesh lawyer, please get in touch with the Firm these days by calling 800-511-5092.

&#13

*fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm079028.htm&#13

**fda.gov/MedicalDevices/Security/AlertsandNotices/PublicHealthNotifications/ucm061976.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated person and class action lawsuits nationwide given that 1993, such as these who have been harmed by dangerous drugs, defective healthcare devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Marketing.

Da Vinci Lawsuit News: Bernstein Liebhard LLP Comments on Enhanced Use of Robotic Surgery to Treat Low-Grade Prostate Cancer

Posted on by


New York, New York (PRWEB) July 04, 2013

As da Vinci lawsuit claims alleging injury due to the use of the da Vinci Surgical Technique continue to move forward in courts all through the country, Bernstein Liebhard LLP notes that a new study has located that robotic surgery is being increasingly used to treat men with low-grade prostate cancer, even even though these varieties of procedures could not offer you them any added rewards. According to the study, which was published in the Journal of the American Medical Association on June 26th, the use of robotic surgery and other advance treatments in males with low-grade prostate cancer rose from 32 percent to 44 percent amongst 2004 and 2009.*

&#13

Low-grade prostate cancer is defined as slow-increasing cancer that doesnt pose a threat to a patients life. According to a report from NPR.com, the new study has raised issues, as there is small data to indicate that robotic surgery gives added advantages to individuals with this type of prostate cancer, and might even have harmful effects. Robotic procedures are also far far more high-priced compared to standard types of surgery and radiation.**

&#13

As the NPR report points out, several sufferers are drawn to robotic procedures because of marketing and advertising claims promising shorter recoveries and other benefits. However, as the developing quantity of da Vinci surgery lawsuits makes clear, the true dangers of robotic surgery nevertheless want to be fully evaluated, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and health-related devices. The Firm is presently providing free legal evaluations to individuals who allegedly suffered severe robotic surgery complications in procedures involving the da Vinci Surgical Technique, including da Vinci prostatectomy.

&#13

Da Vinci Surgery Lawsuits&#13

The da Vinci Surgical System was brought to industry in 2000 by Intuitive Surgical, Inc., and is the only robotic surgery platform approved in the U.S. for soft tissue procedures. According to a June 14th report from NBC News, the robot was utilised in more than 400,000 procedures final year, like thousands of men who underwent a da Vinci prostatectomy. The very same broadcast also revealed that the U.S. Food &amp Drug Administration (FDA) has received much more than 200 reports of da Vinci patients who suffered burns, cuts and infections since 2007, such as 89 that involved patient deaths. The developing number of da Vinci complications has attracted scrutiny from the FDA, and in January it launched a survey of medical doctors to determine if the increase was related to a problem with the technology. ***

&#13

On Might 30th, the FDA issued a 483 letter to Intuitive Surgical soon after an agency inspection of its headquarters revealed that the organization had not informed the FDA of a letter it sent to buyers in October 2011 concerning a problem with the da Vinci that had the potential to harm individuals. According to the FDA letter, Intuitive Surgical had received 134 complaints and filed 82 healthcare device reports associated to tip cover issues amongst January 2010 and December 2011 that allowed electricity to arc, or jump, inside individuals during surgery.**** Just weeks prior, on May 8th, Intuitive sent an Urgent Healthcare Device Notification to its clients after figuring out that micro-cracks in an instrument used with the da Vinci could result in surgical burns. The business has redesigned the instrument and is now shipping replacements.*****

&#13

Intuitive Surgical also acknowledged in an April 19th filing with the U.S. Securities and Exchange Commission that it had been named in 26 da Vinci surgery lawsuits filed on behalf of patients who allegedly suffered critical complications in robotic procedures.****** Although Intuitive lately won the nations 1st trial involving a da Vinci lawsuit, Reuters reported on May possibly 28th that plaintiffs attorneys expect hundreds of similar filings in the future. ******* (Estate of Fred E. Taylor v. Intuitive Surgical Inc., 09-two-03136-five, Superior Court, State of Washington, Kitsap County (Port Orchard))

&#13

Victims of severe injuries allegedly brought on by the da Vinci Surgical System could be entitled to compensation for healthcare expenditures, lost wages, discomfort and suffering, and far more. To find out much more about filing a da Vinci surgery lawsuit, please visit Bernstein Liebhard LLPs site. Free of charge, no-obligation legal evaluations can also be arranged by calling 800-511-5092.

&#13

*jama.jamanetwork.com/article.aspx?articleid=1700496&#13

**npr.org/blogs/wellness/2013/06/26/195835806/males-pick-robotic-surgery-for-prostate-cancer-despite-risks&#13

***rockcenter.nbcnews.com/_news/2013/06/14/18958967-robotic-surgery-is-high-tech-tour-de-force-but-is-it-secure&#13

****fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM358468.pdf&#13

*****.cnbc.com/id/100726886&#13

****** sec.gov/Archives/edgar/information/1035267/000119312513162385/d508282d10q.htm &#13

*******newsandinsight.thomsonreuters.com/Legal/News/2013/05_-_Could/Intuitive_Surgical_wins_case_over_robotic_surgery_method/

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated individual and class action lawsuits nationwide since 1993, including those who have been harmed by unsafe drugs, defective healthcare devices and consumer merchandise. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the past 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

ten East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Marketing.

Januvia Lawsuit Web site Launched by Bernstein Liebhard LLP to Give Information About Possible Januvia Side Effects, Such as Januvia Pancreatic Cancer

Posted on by


New York, New York (PRWEB) July 03, 2013

A new Januvia lawsuit internet site has been launched by Bernstein Liebhard LLP to supply details to men and women who might be concerned about potential Januvia side effects, such as Januvia pancreatic cancer, Januvia pancreatitis and Januvia thyroid cancer. The internet site will also be updated regularly with the most existing data concerning the increasing litigation surrounding the type 2 diabetes drug and its alleged association with pancreatic cancer, pancreatitis, and thyroid cancer.

&#13

Januvia and comparable variety 2 diabetes drugs are coming beneath elevated scrutiny amid concerns that they may possibly boost the danger that a patient will develop pancreatic cancer, pancreatitis or thyroid cancer. This site will offer valuable info to worried sufferers and their households concerning the prospective risks connected with Januvia, as effectively as their choices for legal recourse, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and healthcare devices. The Firm is currently offering free of charge Januvia lawsuit consultations to any person who might have been harmed right after taking Januvia or a similar drug.

&#13

Januvia Lawsuits

&#13

Januvia belongs to a class of type2 diabetes drugs identified as incretin mimetics, which support regulate blood sugar by stimulating insulin production by the pancreas. The U.S. Food &amp Drug Administration (FDA) announced in March that it was investigating incretin mimetics following benefits from an unpublished study indicated these drugs may possibly cause pre-cancerous adjustments in the pancreas.* Most recently, a report published June 10th in the British Health-related Journal revealed previously unpublished information that indicated the producers of incretin mimetics could have downplayed the drugs possible to harm the pancreas.**

&#13

In 2009, a caution relating to a possible Januvia pancreatitis threat was added to the drugs label right after the FDA became conscious of 88 post-advertising cases of acute pancreatitis in individuals taking Januvia.*** In 2011, a study published in Gastroenterology discovered that use of Januvia appeared to increase the danger of pancreatitis and pancreatic cancer, while two circumstances of thyroid cancer have been also reported in the individuals who took Januvia.****

&#13

Court documents indicate that Merck &amp Co. has been named in a quantity of lawsuits filed on behalf of individuals who allegedly developed Januvia pancreatic cancer, Januvia pancreatitis, or Januvia thyroid cancer. The U.S. Judicial Panel on Multidistrict Litigation (JPML) is scheduled to hear Oral Arguments on July 25, 2013, relating to the proposed establishment of a multidistrict litigation for all federally-filed claims involving incretin mimetics, Which includes Januvia lawsuits. (In Re: Incretins Items Liability, Sales and Advertising and marketing Litigation, MDL 2452, JPML)

&#13

Individuals who have allegedly developed Januvia pancreatic cancer, thyroid cancer or pancreatitis could be entitled to compensation for medical bills, lost wages, pain and suffering and far more. To learn more about filing a Januvia lawsuit, please check out Bernstein Liebhard LLPs internet site. For a lot more info, please call 800-511-5092.

&#13

*fda.gov/Drugs/DrugSafety/ucm343187.htm&#13

**bmj.com/open-data/incretin#alternate BMJ, June 10, 2013&#13

**fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183800.htm September 25, 2009 &#13

***gastrojournal.org/article/S0016-5085%2811%2900172-7/abstract, Gastroenterology, February 21, 2011

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide considering that 1993, including these who have been harmed by hazardous drugs, defective health-related devices and consumer items. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the leading plaintiffs firms in the country, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Infuse Bone Graft Lawsuit Site Launched By Hissey Kientz, LLP Law Firm

Posted on by


Austin, TX (PRWEB) July 01, 2013

The law firm of Hissey Kientz, LLP is announcing the launch of its new website, Medtronic Bone Graft Lawyers (http://medtronicbonegraftlawyers.com/). The web site will serve as a source for news and legal info for patients and their families who have experienced complications soon after receiving a Medtronic Infuse Bone Graft for the duration of surgery.

&#13

A two-year analysis of Medtronic health-related information conducted by prominent universities recently determined that use of the Infuse Bone Grafts throughout surgery is no a lot more effective than conventional operations for spinal surgeries although creating additional dangers. The evaluation, published in the Annals of Internal Medicine on June 18th, 2013, linked the Medtronic Infuse Bone Graft to bone spurs, paralysis, retrograde ejaculation and urogenital difficulties.

&#13

Researchers also concluded that previous Medtronic studies praising the effectiveness of the Infuse Bone Graft involved bias and selective reporting.

&#13

The U.S. Food and Drug Administration (FDA) approved the Infuse Bone Graft in 2002 for use in spinal fusion surgeries in the decrease spine only. Nevertheless, a 2013 Bloomberg Businessweek report noted that Medtronic promoted off-label (unapproved) use of the bone graft in the upper spine and neck.

&#13

The FDA released a notification in 2008 warning that off-label use of the Infuse Bone Graft in the upper spine could cause excessive neck swelling, compressed airways, difficulty breathing, difficulties swallowing and nerve harm.

&#13

Sufferers who have seasoned excessive bone growth, paralysis, osteolytis or male sterility soon after getting a Medtronic Infuse Bone Graft might wish to speak with a lawyer to discover out if they are eligible to file a lawsuit. For far more details about no matter whether you may have a case, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454 or by e mail at information(at)hkllp(dot)com.

&#13

About Hissey Kientz, LLP &#13

Hissey Kientz, LLP represents people experiencing complications from Medtronic Infuse Bone Grafts, as well as victims of mesothelioma and other asbestos-associated ailments, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa, Paxil and Effexor, issues with transvaginal mesh, Stryker and BioMet hip replacements, GranuFlo dialysis concentrate and other defective drugs and medical devices.

&#13
&#13
&#13
&#13
&#13